Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.20.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:    
Net loss $ (5,794) $ (4,154)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 4 6
Stock-based compensation 1,755 889
Noncash interest expense 10
Change in fair value of derivative liabilities (102)
Warrant modification expense 412
Loss on extinguishment of derivative liability 288
Changes in operating assets and liabilities:    
Trade receivable (16) (71)
Other accounts receivable and prepaid expenses (173) (34)
Inventory 23 (68)
Other assets (4)
Trade payables (64) 25
Other accounts payable and accrued expenses (167) (182)
Accrued severance pay, net (50) 43
Net cash used in operating activities (3,874) (3,550)
Cash flows from investing activities:    
Purchases of property plant and equipment (8)
Net cash used in investing activities (8)
Cash flows from financing activities:    
Net proceeds from exercise of warrants 91
Proceeds from issuance of convertible notes and warrants 475
Payments of convertible notes (475)
Proceeds from sale of common stock 630
Proceeds from issuance of Series E Preferred Stock 3,620
Proceeds from exercise of options 66 3
Net cash provided by financing activities 4,316 94
Net increase in cash and cash equivalents 442 (3,464)
Cash and cash equivalents at beginning of period 896 4,360
Cash and cash equivalents at end of period 1,338 896
Supplemental non-cash financing and investing activities:    
Cash paid for interest 5
Cash paid for taxes
Reclass warrants to non-derivative instruments 196
Exchange of common Stock into Preferred Stock 275 250
Discount on convertible notes $ 414